Allen D. Roses - Concepedia

Author

Allen D. Roses

Duke Medical Center

Also Known As

A D Roses, A D. Roses, A Roses, A. Bardoni, A. D. ROSES, A. D. Roses, A. Roses, A.D Roses, A.D. Roses, ALLEN D. ROSES

494

Publications

55.7K

Citations

H-Index

265

Concepts

All Affiliations

Duke Medical Center Duke University Duke University Hospital Research Triangle Park Foundation GlaxoSmithKline (United States)

About

Allen D. Roses is an author at Duke Medical Center specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	71	165	24.3K
2	Health Sciences	24	24	3.1K
3	Natural Sciences	14	15	1.4K
4	Engineering	3	3	646
5	Nursing	1	1	44

Allen D. Roses

256

Publications

47.1K

Citations

H-Index

Page 1

	Year	Citations
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families Elizabeth H. Corder, Ann M. Saunders, Warren J. Strittmatter, Science	1993	9.3K
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease Robin Sherrington, Yuh‐Jin Liang, Ekaterina Rogaeva, Nature Neurodegenerative DiseasesEarly-onset Familial AlzheimerAlzheimer's DiseaseGenetic DisorderGenetics	1995	4K
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease Ann M. Saunders, Warren J. Strittmatter, D. E. Schmechel, Neurology	1993	3.8K
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease Elizabeth H. Corder, Ann M. Saunders, Neil Risch, Nature Genetics Alzheimer's DiseaseAgingApolipoprotein EDementiaNeurochemical Biomarkers	1994	1.9K
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. D. E. Schmechel, Ann M. Saunders, Warren J. Strittmatter, Proceedings of the National Academy of Sciences Neurochemical BiomarkersAlzheimer's DiseaseProtein MisfoldingNeurologyLate-onset Alzheimer Disease	1993	1.5K
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Warren J. Strittmatter, Karl H. Weisgraber, Daoyuan Huang, Proceedings of the National Academy of Sciences	1993	1.4K
Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways John Cogswell, James M. Ward, Ian A. Taylor, Journal of Alzheimer s Disease	2008	925
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir Seth Hetherington, Arlene R. Hughes, Michael Mosteller, The Lancet HistocompatibilityImmunogeneticsAllergyAutoimmune DiseasePathogenesis	2002	806
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease Gary W. Small, Linda M. Ercoli, Daniel Silverman, Proceedings of the National Academy of Sciences NeuropsychologyAgingNeurochemical BiomarkersPositron Emission TomographyAlzheimer's Disease	2000	790
A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci Sreekumar Pillai, Dongliang Ge, Guohua Zhu, PLoS Genetics	2009	781

Page 1